Ionis Pharmaceuticals IONS Amount that if recognized, would affect the effective tax rate or regulatory liability
Amount that if recognized, would affect the effective tax rate or regulatory liability at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability?
- Ionis Pharmaceuticals (IONS) reported amount that if recognized, would affect the effective tax rate or regulatory liability of $200K in Q4 2025.
- What is the long-term trend for Ionis Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability has grown at a -18.4% compound annual growth rate (CAGR), from $300K to $200K.